Pitfalls of converting practice guidelines into quality measures - Lessons learned from a VA performance measure

被引:144
作者
Walter, LC
Davidowitz, NP
Heineken, PA
Covinsky, KE
机构
[1] Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 291卷 / 20期
关键词
D O I
10.1001/jama.291.20.2466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Department of Veterans Affairs (VA) manages the largest health care system in the United States, and the Institute of Medicine has recommended that many practices of VA quality measurement be applied to the US health care system as a whole. The VA measures quality of care at all of its sites by assessing adherence rates to performance measures, which generally are derived from evidence-based practice guidelines. Higher adherence rates are used as evidence of better quality of care. However, there are problems with converting practice guidelines, intended to offer guidance to clinicians, into performance measures that are meant to identify poor-quality care. We suggest a more balanced perspective on the use of performance measures to define quality by delineating conceptual problems with the conversion of practice guidelines into quality measures. Focusing on colorectal cancer screening, we use a case study at 1 VA facility to illustrate pitfalls that can cause adherence rates to guideline-based performance measures to be poor indicators of the quality of cancer screening. Pitfalls identified included (1) not properly considering illness severity of the sample population audited for adherence to screening, (2) not distinguishing screening from diagnostic procedures when setting achievable target screening rates, and (3) not accounting for patient preferences or clinician judgment when scoring performance measures. For many patients with severe comorbid illnesses or strong preferences against screening, the risks of colorectal cancer screening outweigh the benefits, and the decision to not screen may reflect good quality of care. Performance measures require more thoughtful specification and interpretation to avoid defining high testing rates as good quality of care regardless of who received the test, why it was performed, or whether the patient wanted it.
引用
收藏
页码:2466 / 2470
页数:5
相关论文
共 33 条
  • [1] Screening for colorectal cancer: Recommendation and rationale
    Berg, AO
    Allan, JD
    Frame, PS
    Homer, CJ
    Johnson, MS
    Klein, JD
    Lieu, TA
    Mulrow, CD
    Orleans, CT
    Peipert, JF
    Pender, NJ
    Siu, AL
    Teutsch, SM
    Westhoff, C
    Woolf, SH
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) : 129 - 131
  • [2] The unintended consequences of measuring quality on the quality of medical care
    Casalino, LP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1147 - 1150
  • [3] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [4] Demakis JG, 2000, MED CARE, V38, pS17
  • [5] *DEP VET AFF OFF I, 2003, 010154488 DEP VET AF
  • [6] Measuring quality of care and performance from a population health care perspective
    Derose, SF
    Petitti, DB
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 2003, 24 : 363 - 384
  • [7] Performance measurement: Problems and solutions
    Eddy, DM
    [J]. HEALTH AFFAIRS, 1998, 17 (04) : 7 - 25
  • [8] Bringing the patient back in: Guidelines, practice variations, and the social context of medical practice
    Greer, AL
    Goodwin, JS
    Freeman, JL
    Wu, ZH
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (04) : 747 - 761
  • [9] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [10] What is the right cancer screening rate?
    Harris, R
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) : 732 - 734